Christopher Mutz sold $425K of ANI Pharmaceuticals (ANIP)

Executed Mar 6, disclosed Mar 10, 4 days later.

Value, as filed

$425K

5,723 sh across 2 lots

Executed

Mar 6

the trade date, as filed

Disclosed

Mar 10

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christopher Mutz HEAD OF RARE DISEASE profile →

Christopher Mutz (HEAD OF RARE DISEASE) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $538K of ANIP (7,032 sh × $76.55, as filed), executed Feb 12.

The name

ANIP

ANI Pharmaceuticals, Inc. ANIP · Healthcare · 47 filings in 24 months ticker →

Healthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Mutz in ANIP

ANIPSALE ANI Pharmaceuticals, Inc. $227K
3,162 sh × $71.64
Exec Mar 13
Filed Mar 13 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $415K
5,323 sh × $78.02
Exec Feb 20
Filed Feb 23 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $538K
7,032 sh × $76.55
Exec Feb 12
Filed Feb 17 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $242K
4,000 sh × $60.45
Exec May 14 2025
Filed May 15 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. $375K
6,500 sh × $57.70
Exec Nov 15 2024
Filed Nov 18 2024 · 5:30 PM ET